| Name | P2X3 antagonist 38 |
|---|---|
| Synonyms | Cbamic acid, N-[(4S)-4,5-dihydro-3-(4-methylphenyl)-1-[[[(1R)-1-[2-(trifluoromethyl)-5-pyrimidinyl]ethyl]amino]carbonyl]-1H-pyrazol-4-yl]-N-methyl-, ethyl ester |
| Description | P2X3 antagonist 38 (compound 4) is a potent and orally active P2X3 antagonist with IC50 values of 0.132, 0.165, 0.421 µM for hP2X3, rP2X3, gpP2X3, respectively[1]. |
|---|---|
| Related Catalog | |
| Target |
P2X3 Receptor:0.132 μM (IC50) |
| References |
| Molecular Formula | C22H25F3N6O3 |
|---|---|
| Molecular Weight | 478.47 |